Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06701760
PHASE2
Sodium Lactate in Severe TBI
Sponsor: University of California, Los Angeles
View on ClinicalTrials.gov
Summary
This is a safety phase 2 clinical trial of intravenous infusion of sodium lactate in patients with severe TBI. This study is intended for patients in the acute setting in an intensive care unit at centers that have been selected to participate in this trial. This is a proof of safety study and biomarker response study.
Official title: Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
264
Start Date
2028-01-10
Completion Date
2038-07-01
Last Updated
2026-01-16
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sodium Lactate
sodium lactate
DRUG
placebo
infusion of sodium chloride